Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vocal Cord Paralysis | 20 | 2025 | 66 | 9.080 |
Why?
|
| Vocal Cords | 19 | 2025 | 61 | 5.380 |
Why?
|
| Laryngoscopy | 17 | 2024 | 158 | 5.110 |
Why?
|
| Larynx | 11 | 2024 | 72 | 4.730 |
Why?
|
| Deglutition Disorders | 11 | 2025 | 140 | 4.470 |
Why?
|
| Laryngoplasty | 6 | 2024 | 28 | 3.210 |
Why?
|
| Voice Quality | 8 | 2024 | 21 | 3.000 |
Why?
|
| Dysphonia | 7 | 2025 | 16 | 2.850 |
Why?
|
| Recurrent Laryngeal Nerve | 5 | 2025 | 9 | 2.650 |
Why?
|
| Tracheostomy | 9 | 2024 | 215 | 2.510 |
Why?
|
| Vocal Cord Dysfunction | 4 | 2022 | 8 | 2.020 |
Why?
|
| Tracheal Diseases | 3 | 2024 | 14 | 1.850 |
Why?
|
| Ultrasonography | 5 | 2021 | 972 | 1.830 |
Why?
|
| Laryngostenosis | 6 | 2023 | 37 | 1.810 |
Why?
|
| Postoperative Complications | 11 | 2024 | 3113 | 1.650 |
Why?
|
| Cough | 4 | 2025 | 99 | 1.640 |
Why?
|
| Glottis | 3 | 2023 | 29 | 1.600 |
Why?
|
| Deglutition | 5 | 2023 | 57 | 1.410 |
Why?
|
| Speech | 2 | 2025 | 70 | 1.410 |
Why?
|
| Voice Disorders | 3 | 2018 | 16 | 1.400 |
Why?
|
| Cutaneous Fistula | 2 | 2024 | 21 | 1.350 |
Why?
|
| Laryngeal Diseases | 4 | 2023 | 30 | 1.350 |
Why?
|
| Voice | 3 | 2025 | 16 | 1.240 |
Why?
|
| Tracheotomy | 3 | 2024 | 33 | 1.230 |
Why?
|
| Female | 64 | 2025 | 71087 | 1.200 |
Why?
|
| Male | 60 | 2025 | 65158 | 1.200 |
Why?
|
| Infant | 26 | 2024 | 13300 | 1.150 |
Why?
|
| Retrospective Studies | 36 | 2025 | 17648 | 1.150 |
Why?
|
| Nerve Transfer | 2 | 2025 | 9 | 1.130 |
Why?
|
| Aorta, Thoracic | 3 | 2018 | 536 | 1.130 |
Why?
|
| Child | 38 | 2025 | 26239 | 1.090 |
Why?
|
| Bronchoscopy | 4 | 2021 | 179 | 1.080 |
Why?
|
| Laryngoscopes | 3 | 2022 | 71 | 1.040 |
Why?
|
| Humans | 82 | 2025 | 131504 | 1.010 |
Why?
|
| Reoperation | 3 | 2024 | 835 | 1.010 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2021 | 2116 | 0.980 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2024 | 62 | 0.970 |
Why?
|
| Laser Therapy | 3 | 2020 | 239 | 0.970 |
Why?
|
| Speech Acoustics | 1 | 2025 | 9 | 0.930 |
Why?
|
| Speech Production Measurement | 1 | 2025 | 19 | 0.930 |
Why?
|
| Voice Training | 2 | 2016 | 6 | 0.910 |
Why?
|
| Singing | 2 | 2016 | 9 | 0.900 |
Why?
|
| Child, Preschool | 23 | 2025 | 15047 | 0.890 |
Why?
|
| Airway Obstruction | 4 | 2020 | 177 | 0.890 |
Why?
|
| Down Syndrome | 2 | 2020 | 233 | 0.850 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 3 | 2019 | 14 | 0.780 |
Why?
|
| Trachea | 2 | 2024 | 209 | 0.780 |
Why?
|
| Epiglottis | 2 | 2023 | 8 | 0.740 |
Why?
|
| Hypopharynx | 2 | 2025 | 7 | 0.730 |
Why?
|
| Pharyngeal Diseases | 2 | 2025 | 17 | 0.730 |
Why?
|
| Transition to Adult Care | 1 | 2024 | 134 | 0.710 |
Why?
|
| Macroglossia | 1 | 2020 | 2 | 0.680 |
Why?
|
| Preceptorship | 1 | 2021 | 28 | 0.680 |
Why?
|
| Adolescent | 18 | 2025 | 20917 | 0.670 |
Why?
|
| Polyps | 2 | 2023 | 41 | 0.670 |
Why?
|
| Electromyography | 2 | 2019 | 141 | 0.670 |
Why?
|
| Fluoroscopy | 4 | 2021 | 100 | 0.670 |
Why?
|
| Granuloma, Pyogenic | 1 | 2020 | 6 | 0.670 |
Why?
|
| Pharynx | 3 | 2020 | 64 | 0.670 |
Why?
|
| Heart Defects, Congenital | 4 | 2021 | 1894 | 0.640 |
Why?
|
| Quality of Life | 5 | 2024 | 2107 | 0.640 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 86 | 0.630 |
Why?
|
| Laryngeal Nerves | 1 | 2019 | 3 | 0.620 |
Why?
|
| Edema | 2 | 2020 | 139 | 0.620 |
Why?
|
| Treatment Outcome | 16 | 2024 | 12936 | 0.610 |
Why?
|
| DiGeorge Syndrome | 1 | 2019 | 81 | 0.590 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2018 | 37 | 0.580 |
Why?
|
| Croup | 1 | 2018 | 14 | 0.570 |
Why?
|
| Case-Control Studies | 8 | 2019 | 3452 | 0.570 |
Why?
|
| Prospective Studies | 13 | 2024 | 6485 | 0.570 |
Why?
|
| Middle Aged | 21 | 2025 | 28839 | 0.560 |
Why?
|
| Laryngismus | 1 | 2018 | 4 | 0.560 |
Why?
|
| Laryngeal Muscles | 1 | 2018 | 5 | 0.550 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 80 | 0.550 |
Why?
|
| Respiratory Aspiration | 2 | 2017 | 11 | 0.540 |
Why?
|
| Phonation | 2 | 2021 | 6 | 0.540 |
Why?
|
| Crying | 1 | 2017 | 12 | 0.540 |
Why?
|
| Chondrosarcoma | 1 | 2017 | 13 | 0.530 |
Why?
|
| Respiratory Tract Fistula | 1 | 2017 | 17 | 0.530 |
Why?
|
| Smartphone | 1 | 2017 | 46 | 0.530 |
Why?
|
| Zenker Diverticulum | 2 | 2019 | 4 | 0.520 |
Why?
|
| Sialadenitis | 1 | 2016 | 1 | 0.510 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 206 | 0.510 |
Why?
|
| Device Removal | 2 | 2021 | 222 | 0.500 |
Why?
|
| Laryngeal Neoplasms | 1 | 2017 | 85 | 0.500 |
Why?
|
| Esophageal Diseases | 1 | 2016 | 33 | 0.490 |
Why?
|
| Intraoperative Care | 1 | 2017 | 122 | 0.490 |
Why?
|
| Actinomycosis | 1 | 2016 | 8 | 0.490 |
Why?
|
| Thyroid Cartilage | 1 | 2015 | 3 | 0.470 |
Why?
|
| Mobile Applications | 1 | 2017 | 114 | 0.470 |
Why?
|
| Observer Variation | 4 | 2019 | 319 | 0.470 |
Why?
|
| Ultrasonography, Doppler | 1 | 2016 | 184 | 0.460 |
Why?
|
| Osteochondrodysplasias | 1 | 2015 | 73 | 0.460 |
Why?
|
| Time Factors | 8 | 2024 | 6273 | 0.450 |
Why?
|
| Aortic Diseases | 1 | 2017 | 189 | 0.450 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 274 | 0.440 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2021 | 1170 | 0.440 |
Why?
|
| Infant, Newborn | 10 | 2023 | 8589 | 0.440 |
Why?
|
| Respiratory Tract Infections | 2 | 2020 | 292 | 0.430 |
Why?
|
| Tracheal Stenosis | 1 | 2014 | 31 | 0.430 |
Why?
|
| Adult | 17 | 2025 | 31666 | 0.430 |
Why?
|
| Calcinosis | 1 | 2015 | 187 | 0.420 |
Why?
|
| Recovery of Function | 4 | 2023 | 456 | 0.420 |
Why?
|
| Larynx, Artificial | 1 | 2013 | 8 | 0.420 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2014 | 48 | 0.410 |
Why?
|
| Education, Professional | 1 | 2013 | 10 | 0.410 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2021 | 155 | 0.410 |
Why?
|
| Stroboscopy | 3 | 2019 | 4 | 0.410 |
Why?
|
| Follow-Up Studies | 8 | 2024 | 5277 | 0.410 |
Why?
|
| Papillomavirus Infections | 2 | 2020 | 389 | 0.390 |
Why?
|
| Lasers, Gas | 1 | 2012 | 6 | 0.380 |
Why?
|
| Anticoagulants | 1 | 2017 | 594 | 0.370 |
Why?
|
| Speech Therapy | 2 | 2025 | 15 | 0.370 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2016 | 490 | 0.370 |
Why?
|
| Nasal Cavity | 1 | 2012 | 55 | 0.360 |
Why?
|
| Young Adult | 9 | 2024 | 10092 | 0.360 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2011 | 40 | 0.350 |
Why?
|
| Scoliosis | 2 | 2024 | 145 | 0.350 |
Why?
|
| Endoscopy | 3 | 2022 | 282 | 0.340 |
Why?
|
| Chronic Disease | 3 | 2025 | 1233 | 0.340 |
Why?
|
| Health Behavior | 1 | 2013 | 390 | 0.330 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 2985 | 0.320 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 1910 | 0.320 |
Why?
|
| Botulinum Toxins | 1 | 2011 | 125 | 0.320 |
Why?
|
| Pilot Projects | 3 | 2023 | 1450 | 0.310 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 4037 | 0.290 |
Why?
|
| Oxygen | 1 | 2012 | 552 | 0.290 |
Why?
|
| Incidence | 4 | 2025 | 3344 | 0.290 |
Why?
|
| Aged | 10 | 2025 | 21238 | 0.280 |
Why?
|
| Airway Extubation | 2 | 2020 | 70 | 0.280 |
Why?
|
| Mastoiditis | 1 | 2008 | 33 | 0.280 |
Why?
|
| Reference Values | 3 | 2016 | 691 | 0.280 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 2143 | 0.270 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 6916 | 0.260 |
Why?
|
| Injections | 2 | 2017 | 114 | 0.260 |
Why?
|
| Speech-Language Pathology | 2 | 2019 | 13 | 0.260 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 902 | 0.260 |
Why?
|
| Anxiety | 1 | 2013 | 1002 | 0.250 |
Why?
|
| United States | 7 | 2025 | 11794 | 0.250 |
Why?
|
| Atrophy | 2 | 2025 | 251 | 0.250 |
Why?
|
| Otolaryngology | 2 | 2021 | 118 | 0.240 |
Why?
|
| Cohort Studies | 3 | 2021 | 5120 | 0.240 |
Why?
|
| Intubation, Intratracheal | 2 | 2023 | 288 | 0.240 |
Why?
|
| Streptococcus pneumoniae | 1 | 2008 | 389 | 0.230 |
Why?
|
| Phonetics | 1 | 2025 | 36 | 0.230 |
Why?
|
| Inpatients | 2 | 2022 | 545 | 0.230 |
Why?
|
| Constriction, Pathologic | 2 | 2023 | 227 | 0.230 |
Why?
|
| Diskectomy | 1 | 2024 | 13 | 0.220 |
Why?
|
| Surgical Stomas | 1 | 2024 | 8 | 0.210 |
Why?
|
| Amyloidosis | 1 | 2025 | 71 | 0.210 |
Why?
|
| Bandages | 1 | 2024 | 55 | 0.210 |
Why?
|
| Confidence Intervals | 2 | 2016 | 272 | 0.210 |
Why?
|
| Linear Models | 1 | 2025 | 695 | 0.200 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 3090 | 0.200 |
Why?
|
| Health Care Surveys | 1 | 2024 | 282 | 0.200 |
Why?
|
| Spinal Fusion | 1 | 2024 | 118 | 0.200 |
Why?
|
| Biopsy | 2 | 2017 | 1249 | 0.190 |
Why?
|
| Vascular Surgical Procedures | 2 | 2018 | 539 | 0.190 |
Why?
|
| Patient Compliance | 1 | 2025 | 469 | 0.180 |
Why?
|
| Recurrence | 3 | 2021 | 1478 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2024 | 501 | 0.180 |
Why?
|
| Aerosols | 1 | 2021 | 60 | 0.170 |
Why?
|
| Evaluation Studies as Topic | 1 | 2021 | 235 | 0.170 |
Why?
|
| Age Factors | 2 | 2025 | 2870 | 0.170 |
Why?
|
| Leukoplakia | 1 | 2020 | 3 | 0.170 |
Why?
|
| Ethosuximide | 1 | 2020 | 13 | 0.170 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2020 | 9 | 0.170 |
Why?
|
| Papilloma | 1 | 2020 | 22 | 0.170 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2024 | 274 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 2297 | 0.160 |
Why?
|
| Bevacizumab | 1 | 2020 | 59 | 0.160 |
Why?
|
| Software | 1 | 2025 | 752 | 0.160 |
Why?
|
| Publishing | 1 | 2021 | 105 | 0.160 |
Why?
|
| Cricoid Cartilage | 1 | 2020 | 14 | 0.160 |
Why?
|
| Surgical Flaps | 1 | 2022 | 187 | 0.160 |
Why?
|
| Vomiting | 1 | 2020 | 104 | 0.160 |
Why?
|
| Esophagoscopes | 1 | 2019 | 5 | 0.150 |
Why?
|
| Single-Blind Method | 1 | 2019 | 241 | 0.150 |
Why?
|
| Airway Management | 1 | 2019 | 68 | 0.150 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 131 | 0.150 |
Why?
|
| Neck | 2 | 2017 | 145 | 0.150 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2018 | 9 | 0.150 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 162 | 0.140 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 180 | 0.140 |
Why?
|
| Hearing Aids | 1 | 2018 | 32 | 0.140 |
Why?
|
| Prognosis | 4 | 2020 | 4951 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2022 | 322 | 0.140 |
Why?
|
| Esophagoscopy | 1 | 2019 | 174 | 0.140 |
Why?
|
| Standard of Care | 1 | 2018 | 135 | 0.140 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 236 | 0.130 |
Why?
|
| Laryngectomy | 1 | 2017 | 31 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 2018 | 155 | 0.130 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2017 | 13 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 611 | 0.130 |
Why?
|
| Texas | 2 | 2017 | 3614 | 0.130 |
Why?
|
| Social Class | 1 | 2018 | 211 | 0.130 |
Why?
|
| Parotid Gland | 1 | 2016 | 18 | 0.130 |
Why?
|
| Pneumonia | 1 | 2020 | 344 | 0.130 |
Why?
|
| Gastroesophageal Reflux | 1 | 2020 | 326 | 0.130 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 316 | 0.120 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 275 | 0.120 |
Why?
|
| Sound Spectrography | 1 | 2016 | 8 | 0.120 |
Why?
|
| Risk Factors | 2 | 2024 | 10952 | 0.120 |
Why?
|
| Acoustics | 1 | 2016 | 22 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2018 | 356 | 0.120 |
Why?
|
| Early Medical Intervention | 1 | 2016 | 31 | 0.120 |
Why?
|
| Postoperative Period | 1 | 2016 | 330 | 0.120 |
Why?
|
| Keloid | 1 | 2015 | 11 | 0.120 |
Why?
|
| Self-Assessment | 1 | 2015 | 59 | 0.120 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 265 | 0.110 |
Why?
|
| Feeding and Eating Disorders | 1 | 2016 | 74 | 0.110 |
Why?
|
| Equipment Design | 2 | 2019 | 553 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2019 | 557 | 0.110 |
Why?
|
| Length of Stay | 2 | 2018 | 1393 | 0.110 |
Why?
|
| Esophageal Atresia | 1 | 2014 | 51 | 0.100 |
Why?
|
| Patient Safety | 1 | 2018 | 444 | 0.100 |
Why?
|
| Acute Disease | 1 | 2016 | 1153 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2013 | 3693 | 0.100 |
Why?
|
| Office Visits | 1 | 2013 | 81 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 695 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1617 | 0.090 |
Why?
|
| Vital Signs | 1 | 2012 | 25 | 0.090 |
Why?
|
| Synkinesis | 1 | 2011 | 2 | 0.090 |
Why?
|
| Surgical Stapling | 1 | 2011 | 17 | 0.090 |
Why?
|
| Algorithms | 1 | 2018 | 1685 | 0.090 |
Why?
|
| Self Care | 1 | 2013 | 231 | 0.090 |
Why?
|
| Psychometrics | 1 | 2015 | 670 | 0.090 |
Why?
|
| Blood Pressure Determination | 1 | 2012 | 119 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3911 | 0.080 |
Why?
|
| Radiography | 1 | 2011 | 760 | 0.080 |
Why?
|
| Disease Progression | 1 | 2015 | 2205 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2012 | 406 | 0.070 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2008 | 92 | 0.070 |
Why?
|
| Serotyping | 1 | 2008 | 171 | 0.070 |
Why?
|
| Temporal Bone | 1 | 2008 | 37 | 0.070 |
Why?
|
| Vaccines, Conjugate | 1 | 2008 | 83 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2012 | 816 | 0.070 |
Why?
|
| Pneumococcal Vaccines | 1 | 2008 | 176 | 0.060 |
Why?
|
| Lactoferrin | 1 | 2007 | 76 | 0.060 |
Why?
|
| Pneumococcal Infections | 1 | 2008 | 279 | 0.060 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2008 | 391 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2008 | 846 | 0.060 |
Why?
|
| Silver | 1 | 2024 | 27 | 0.050 |
Why?
|
| Breathing Exercises | 1 | 2022 | 8 | 0.050 |
Why?
|
| Biofeedback, Psychology | 1 | 2022 | 38 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2024 | 270 | 0.040 |
Why?
|
| Hoarseness | 1 | 2021 | 13 | 0.040 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2021 | 16 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2007 | 631 | 0.040 |
Why?
|
| Poly A | 1 | 2001 | 46 | 0.040 |
Why?
|
| Xenopus | 1 | 2001 | 103 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 758 | 0.040 |
Why?
|
| Xenopus Proteins | 1 | 2001 | 59 | 0.040 |
Why?
|
| Wound Healing | 1 | 2024 | 476 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 3834 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 262 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 221 | 0.040 |
Why?
|
| Body Height | 1 | 2020 | 196 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 434 | 0.040 |
Why?
|
| Hearing | 1 | 2018 | 61 | 0.040 |
Why?
|
| Language Development | 1 | 2018 | 36 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 338 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 1788 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2018 | 140 | 0.030 |
Why?
|
| Language Development Disorders | 1 | 2018 | 178 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1809 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 549 | 0.030 |
Why?
|
| Feeding Methods | 1 | 2016 | 36 | 0.030 |
Why?
|
| Triamcinolone Acetonide | 1 | 2015 | 20 | 0.030 |
Why?
|
| Head | 1 | 2015 | 115 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2018 | 400 | 0.030 |
Why?
|
| Self Concept | 1 | 2015 | 163 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 1682 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1831 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 506 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 303 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 1313 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2007 | 109 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2007 | 769 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2007 | 705 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 1610 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 137 | 0.010 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2001 | 23 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 2001 | 49 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 1347 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 195 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 624 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 455 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 2464 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 414 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 3672 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 1101 | 0.010 |
Why?
|
| Oocytes | 1 | 2001 | 283 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 1018 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 2562 | 0.010 |
Why?
|
| Protein Binding | 1 | 2001 | 1710 | 0.010 |
Why?
|
| Base Sequence | 1 | 2001 | 2782 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2001 | 1005 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 3614 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2001 | 1745 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2001 | 1085 | 0.010 |
Why?
|
| Animals | 2 | 2007 | 34341 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 18473 | 0.000 |
Why?
|